Goldman Sachs
CLX icon

Goldman Sachs’s Clorox CLX Stock Holding History

Goldman Sachs’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,600
Closed -$2.09M – 6255
2021
Q2 		$2.09M Sell
11,600
-2,800
-19% -$511K ﹤0.01% 4162
2021
Q1 		$2.78M Buy
+14,400
New +$2.77M ﹤0.01% 3657
2019
Q1 		– Sell
-26,100
Closed -$4.02M – 5173
2018
Q4 		$4.02M Sell
26,100
-40,600
-61% -$6.32M ﹤0.01% 3059
2018
Q3 		$10M Buy
+66,700
New +$9.48M ﹤0.01% 2458
2018
Q2 		– Sell
-1,200
Closed -$160K – 5694
2018
Q1 		$160K Sell
1,200
-2,400
-67% -$322K ﹤0.01% 5101
2017
Q4 		$535K Sell
3,600
-300
-8% -$40.8K ﹤0.01% 4770
2017
Q3 		$514K Buy
3,900
+1,300
+50% +$175K ﹤0.01% 5064
2017
Q2 		$346K Sell
2,600
-3,900
-60% -$526K ﹤0.01% 5382
2017
Q1 		$876K Sell
6,500
-3,500
-35% -$453K ﹤0.01% 4499
2016
Q4 		$1.2M Buy
10,000
+2,000
+25% +$236K ﹤0.01% 4286
2016
Q3 		$1M Sell
8,000
-700
-8% -$91.7K ﹤0.01% 4397
2016
Q2 		$1.2M Buy
8,700
+3,900
+81% +$506K ﹤0.01% 4043
2016
Q1 		$605K Sell
4,800
-13,800
-74% -$1.75M ﹤0.01% 4560
2015
Q4 		$2.36M Sell
18,600
-3,800
-17% -$472K ﹤0.01% 3482
2015
Q3 		$2.59M Buy
22,400
+8,800
+65% +$988K ﹤0.01% 3532
2015
Q2 		$1.42M Sell
13,600
-14,000
-51% -$1.51M ﹤0.01% 4202
2015
Q1 		$3.05M Sell
27,600
-215,600
-89% -$23.4M ﹤0.01% 3375
2014
Q4 		$25.3M Buy
243,200
+130,700
+116% +$13.1M 0.01% 1656
2014
Q3 		$10.8M Buy
112,500
+77,300
+220% +$6.99M ﹤0.01% 2299
2014
Q2 		$3.22M Sell
35,200
-13,400
-28% -$1.2M ﹤0.01% 3498
2014
Q1 		$4.28M Sell
48,600
-37,700
-44% -$3.31M ﹤0.01% 3197
2013
Q4 		$8.01M Sell
86,300
-79,900
-48% -$7.2M ﹤0.01% 2581
2013
Q3 		$13.6M Buy
166,200
+8,100
+5% +$684K 0.01% 1943
2013
Q2 		$13.1M Buy
+158,100
New +$13.6M 0.01% 1854

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Goldman Sachs's CLX Position: Q1 2026 in Review

Goldman Sachs increased its Clorox (CLX) stake by 45% in Q1 2026, buying an estimated $44.5M and bringing the position to 1,258,596 shares worth $130M. The position accounts for 0.02% of the portfolio, ranked #883.

Goldman Sachs first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $210M in Q1 2020. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Goldman Sachs held 1,258,596 shares of Clorox worth $130M as of Q1 2026.
  • Goldman Sachs bought 392,898 Clorox shares in Q1 2026, an estimated $44.5M.
  • Clorox made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #883 holding.
  • Goldman Sachs first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Clorox position peaked at $210M in Q1 2020.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.